These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2938947

  • 1. Serum bactericidal titer as a predictor of outcome in endocarditis.
    Hackbarth CJ, Chambers HF, Sande MA.
    Eur J Clin Microbiol; 1986 Feb; 5(1):93-7. PubMed ID: 2938947
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [Abstract] [Full Text] [Related]

  • 3. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ.
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG, Basuino L, Chambers HF.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [Abstract] [Full Text] [Related]

  • 5. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [Abstract] [Full Text] [Related]

  • 6. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [Abstract] [Full Text] [Related]

  • 7. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [Abstract] [Full Text] [Related]

  • 8. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB, Moretti A, Stagni G, Ravasio V, Soavi L, Raglio A, Vailati F, Cardaccia A, Santucci A, Papili R, Sgrelli A, Pallotto C, Baldelli F.
    Ann Clin Microbiol Antimicrob; 2011 Jun 09; 10():26. PubMed ID: 21658248
    [Abstract] [Full Text] [Related]

  • 9. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW, Patron RL, Goldstein BP, Archer GL.
    Antimicrob Agents Chemother; 1998 Jun 09; 42(6):1355-60. PubMed ID: 9624475
    [Abstract] [Full Text] [Related]

  • 10. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct 09; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 11. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J.
    Antimicrob Agents Chemother; 2005 Feb 09; 49(2):857-9. PubMed ID: 15673789
    [Abstract] [Full Text] [Related]

  • 12. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Pavie J, Lefort A, Ploy MC, Massias L, Chau F, Garry L, Denis F, Fantin B.
    Antimicrob Agents Chemother; 2003 Jun 09; 47(6):2018-21. PubMed ID: 12760890
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.
    Miró JM, García-de-la-Mària C, Armero Y, de-Lazzari E, Soy D, Moreno A, del Rio A, Almela M, Mestres CA, Gatell JM, Jiménez-de-Anta MT, Marco F, Hospital Clínic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2007 Jul 09; 51(7):2373-7. PubMed ID: 17485502
    [Abstract] [Full Text] [Related]

  • 14. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G, Valdés M, Pérez R, Martín-Luengo F, García A, Soria F, Gómez J.
    Enferm Infecc Microbiol Clin; 1991 Apr 09; 9(4):208-10. PubMed ID: 1830757
    [Abstract] [Full Text] [Related]

  • 15. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA, Courtney KB.
    J Lab Clin Med; 1976 Jul 09; 88(1):118-24. PubMed ID: 1047088
    [Abstract] [Full Text] [Related]

  • 16. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H.
    Antimicrob Agents Chemother; 2001 Dec 09; 45(12):3531-7. PubMed ID: 11709335
    [Abstract] [Full Text] [Related]

  • 17. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
    Voorn GP, Kuyvenhoven J, Goessens WH, Schmal-Bauer WC, Broeders PH, Thompson J, Michel MF.
    Antimicrob Agents Chemother; 1994 Mar 09; 38(3):487-93. PubMed ID: 8203842
    [Abstract] [Full Text] [Related]

  • 18. Value of serum tests in combined drug therapy of endocarditis.
    Drake TA, Hackbarth CJ, Sande MA.
    Antimicrob Agents Chemother; 1983 Nov 09; 24(5):653-7. PubMed ID: 6660846
    [Abstract] [Full Text] [Related]

  • 19. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J, Carrizosa J, Kaye D, Kobasa WD.
    J Lab Clin Med; 1977 Jun 09; 89(6):1262-8. PubMed ID: 864305
    [Abstract] [Full Text] [Related]

  • 20. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM, Keeley JM.
    J Antimicrob Chemother; 1983 Dec 09; 12 Suppl D():65-78. PubMed ID: 6421794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.